Discussion IGF-1 Signaling (2 Viewers)

[paralyzed]

honey is the best igf one signaler carbs and sugar makes it the best igf signaler

 

[paralyzed]

honey is the best igf one signaler carbs and sugar makes it the best igf signaler

Honey can be framed, in a highly elaborated and more technical biochemical context, as a potent modulator of insulin and insulin-like growth factor (IGF-1) signaling pathways due to its unique composition of rapidly bioavailable carbohydrates, minor bioactive compounds, and its metabolic effects on endocrine responses.
At its core, honey is a supersaturated solution primarily composed of monosaccharides—predominantly fructose (~38%) and glucose (~31%)—alongside smaller quantities of disaccharides, oligosaccharides, amino acids, organic acids, vitamins, and polyphenolic compounds. The glucose fraction, in particular, is critical in stimulating pancreatic β-cell activity, leading to insulin secretion. Insulin, beyond its classical role in glucose homeostasis, functions as a key upstream regulator of the IGF-1 axis by enhancing hepatic production of IGF-1 and reducing levels of IGF-binding proteins (especially IGFBP-1), thereby increasing free, bioactive IGF-1 in circulation.
From an endocrinological perspective, the ingestion of honey results in a glycemic response that, while sometimes moderated compared to pure glucose due to its fructose content and matrix effects, still provides a sufficiently robust insulinotropic stimulus. This insulin response activates the PI3K/Akt/mTOR signaling cascade, a central intracellular pathway responsible for anabolic processes such as protein synthesis, cell proliferation, and inhibition of apoptosis. IGF-1 signaling converges on many of these same pathways, particularly through activation of the IGF-1 receptor (IGF1R), a receptor tyrosine kinase that shares significant downstream overlap with insulin signaling.
Fructose, while not directly insulinogenic to the same degree as glucose, plays an indirect but important role. Hepatic metabolism of fructose leads to increased glycogen storage and can influence systemic energy balance, which in turn modulates growth factor signaling. Additionally, fructose metabolism bypasses key regulatory steps in glycolysis, potentially contributing to increased substrate availability for de novo lipogenesis and cellular energy status, factors that can influence mTOR activation and thereby potentiate IGF-related anabolic signaling under certain conditions.
Honey also contains trace amounts of amino acids, including proline, which may contribute marginally to anabolic signaling by supporting protein synthesis and cellular growth pathways. More interestingly, its polyphenols and flavonoids—such as quercetin, kaempferol, and chrysin—can exert modulatory effects on oxidative stress and inflammation. Reduced oxidative stress can enhance insulin sensitivity, thereby amplifying the downstream effects of insulin and IGF-1 signaling. Improved insulin sensitivity means that for a given مقدار of carbohydrate intake, the signaling efficiency through insulin and IGF pathways is enhanced, potentially increasing the net anabolic response.
In a comparative sense, positioning honey as a “superior” IGF-1 signaler relative to other carbohydrate sources would depend on several contextual variables: glycemic index, glycemic load, micronutrient composition, and metabolic health of the individual. While honey does contain additional bioactive compounds absent in refined sugars, the magnitude of its effect on IGF-1 signaling is not orders of magnitude greater in a strict quantitative biochemical sense. The claim of it being “30 times stronger” would not be supported under controlled physiological measurements; however, qualitatively, its combined effects on insulin secretion, hepatic metabolism, and cellular signaling pathways can be described as synergistic.
Furthermore, chronic consumption patterns must be considered. Persistent elevation of insulin and IGF-1 signaling is associated with both anabolic benefits (such as muscle growth and tissue repair) and potential long-term risks (including contributions to insulin resistance and proliferative diseases if dysregulated). Therefore, while honey can acutely enhance signaling through these pathways due to its carbohydrate density and metabolic effects, its role should be understood within the broader framework of nutritional context, dosage, and individual metabolic response.
In summary, honey acts as a biologically active carbohydrate matrix capable of stimulating insulin release, indirectly enhancing IGF-1 bioavailability, and activating key intracellular anabolic pathways such as PI3K/Akt/mTOR. Its additional components may improve signaling efficiency through antioxidant and anti-inflammatory effects. However, its classification as an exceptionally powerful IGF-1 signaler should be interpreted as a nuanced, context-dependent statement rather than a literal exponential superiority over other carbohydrate sources.

 

[Alex4o12]

Honey can be framed, in a highly elaborated and more technical biochemical context, as a potent modulator of insulin and insulin-like growth factor (IGF-1) signaling pathways due to its unique composition of rapidly bioavailable carbohydrates, minor bioactive compounds, and its metabolic effects on endocrine responses.
At its core, honey is a supersaturated solution primarily composed of monosaccharides—predominantly fructose (~38%) and glucose (~31%)—alongside smaller quantities of disaccharides, oligosaccharides, amino acids, organic acids, vitamins, and polyphenolic compounds. The glucose fraction, in particular, is critical in stimulating pancreatic β-cell activity, leading to insulin secretion. Insulin, beyond its classical role in glucose homeostasis, functions as a key upstream regulator of the IGF-1 axis by enhancing hepatic production of IGF-1 and reducing levels of IGF-binding proteins (especially IGFBP-1), thereby increasing free, bioactive IGF-1 in circulation.
From an endocrinological perspective, the ingestion of honey results in a glycemic response that, while sometimes moderated compared to pure glucose due to its fructose content and matrix effects, still provides a sufficiently robust insulinotropic stimulus. This insulin response activates the PI3K/Akt/mTOR signaling cascade, a central intracellular pathway responsible for anabolic processes such as protein synthesis, cell proliferation, and inhibition of apoptosis. IGF-1 signaling converges on many of these same pathways, particularly through activation of the IGF-1 receptor (IGF1R), a receptor tyrosine kinase that shares significant downstream overlap with insulin signaling.
Fructose, while not directly insulinogenic to the same degree as glucose, plays an indirect but important role. Hepatic metabolism of fructose leads to increased glycogen storage and can influence systemic energy balance, which in turn modulates growth factor signaling. Additionally, fructose metabolism bypasses key regulatory steps in glycolysis, potentially contributing to increased substrate availability for de novo lipogenesis and cellular energy status, factors that can influence mTOR activation and thereby potentiate IGF-related anabolic signaling under certain conditions.
Honey also contains trace amounts of amino acids, including proline, which may contribute marginally to anabolic signaling by supporting protein synthesis and cellular growth pathways. More interestingly, its polyphenols and flavonoids—such as quercetin, kaempferol, and chrysin—can exert modulatory effects on oxidative stress and inflammation. Reduced oxidative stress can enhance insulin sensitivity, thereby amplifying the downstream effects of insulin and IGF-1 signaling. Improved insulin sensitivity means that for a given مقدار of carbohydrate intake, the signaling efficiency through insulin and IGF pathways is enhanced, potentially increasing the net anabolic response.
In a comparative sense, positioning honey as a “superior” IGF-1 signaler relative to other carbohydrate sources would depend on several contextual variables: glycemic index, glycemic load, micronutrient composition, and metabolic health of the individual. While honey does contain additional bioactive compounds absent in refined sugars, the magnitude of its effect on IGF-1 signaling is not orders of magnitude greater in a strict quantitative biochemical sense. The claim of it being “30 times stronger” would not be supported under controlled physiological measurements; however, qualitatively, its combined effects on insulin secretion, hepatic metabolism, and cellular signaling pathways can be described as synergistic.
Furthermore, chronic consumption patterns must be considered. Persistent elevation of insulin and IGF-1 signaling is associated with both anabolic benefits (such as muscle growth and tissue repair) and potential long-term risks (including contributions to insulin resistance and proliferative diseases if dysregulated). Therefore, while honey can acutely enhance signaling through these pathways due to its carbohydrate density and metabolic effects, its role should be understood within the broader framework of nutritional context, dosage, and individual metabolic response.
In summary, honey acts as a biologically active carbohydrate matrix capable of stimulating insulin release, indirectly enhancing IGF-1 bioavailability, and activating key intracellular anabolic pathways such as PI3K/Akt/mTOR. Its additional components may improve signaling efficiency through antioxidant and anti-inflammatory effects. However, its classification as an exceptionally powerful IGF-1 signaler should be interpreted as a nuanced, context-dependent statement rather than a literal exponential superiority over other carbohydrate sources.

Good forum man

 

[greysell]

Good forum man

 

[paralyzed]

Honey can be framed, in a highly elaborated and more technical biochemical context, as a potent modulator of insulin and insulin-like growth factor (IGF-1) signaling pathways due to its unique composition of rapidly bioavailable carbohydrates, minor bioactive compounds, and its metabolic effects on endocrine responses.
At its core, honey is a supersaturated solution primarily composed of monosaccharides—predominantly fructose (~38%) and glucose (~31%)—alongside smaller quantities of disaccharides, oligosaccharides, amino acids, organic acids, vitamins, and polyphenolic compounds. The glucose fraction, in particular, is critical in stimulating pancreatic β-cell activity, leading to insulin secretion. Insulin, beyond its classical role in glucose homeostasis, functions as a key upstream regulator of the IGF-1 axis by enhancing hepatic production of IGF-1 and reducing levels of IGF-binding proteins (especially IGFBP-1), thereby increasing free, bioactive IGF-1 in circulation.
From an endocrinological perspective, the ingestion of honey results in a glycemic response that, while sometimes moderated compared to pure glucose due to its fructose content and matrix effects, still provides a sufficiently robust insulinotropic stimulus. This insulin response activates the PI3K/Akt/mTOR signaling cascade, a central intracellular pathway responsible for anabolic processes such as protein synthesis, cell proliferation, and inhibition of apoptosis. IGF-1 signaling converges on many of these same pathways, particularly through activation of the IGF-1 receptor (IGF1R), a receptor tyrosine kinase that shares significant downstream overlap with insulin signaling.
Fructose, while not directly insulinogenic to the same degree as glucose, plays an indirect but important role. Hepatic metabolism of fructose leads to increased glycogen storage and can influence systemic energy balance, which in turn modulates growth factor signaling. Additionally, fructose metabolism bypasses key regulatory steps in glycolysis, potentially contributing to increased substrate availability for de novo lipogenesis and cellular energy status, factors that can influence mTOR activation and thereby potentiate IGF-related anabolic signaling under certain conditions.
Honey also contains trace amounts of amino acids, including proline, which may contribute marginally to anabolic signaling by supporting protein synthesis and cellular growth pathways. More interestingly, its polyphenols and flavonoids—such as quercetin, kaempferol, and chrysin—can exert modulatory effects on oxidative stress and inflammation. Reduced oxidative stress can enhance insulin sensitivity, thereby amplifying the downstream effects of insulin and IGF-1 signaling. Improved insulin sensitivity means that for a given مقدار of carbohydrate intake, the signaling efficiency through insulin and IGF pathways is enhanced, potentially increasing the net anabolic response.
In a comparative sense, positioning honey as a “superior” IGF-1 signaler relative to other carbohydrate sources would depend on several contextual variables: glycemic index, glycemic load, micronutrient composition, and metabolic health of the individual. While honey does contain additional bioactive compounds absent in refined sugars, the magnitude of its effect on IGF-1 signaling is not orders of magnitude greater in a strict quantitative biochemical sense. The claim of it being “30 times stronger” would not be supported under controlled physiological measurements; however, qualitatively, its combined effects on insulin secretion, hepatic metabolism, and cellular signaling pathways can be described as synergistic.
Furthermore, chronic consumption patterns must be considered. Persistent elevation of insulin and IGF-1 signaling is associated with both anabolic benefits (such as muscle growth and tissue repair) and potential long-term risks (including contributions to insulin resistance and proliferative diseases if dysregulated). Therefore, while honey can acutely enhance signaling through these pathways due to its carbohydrate density and metabolic effects, its role should be understood within the broader framework of nutritional context, dosage, and individual metabolic response.
In summary, honey acts as a biologically active carbohydrate matrix capable of stimulating insulin release, indirectly enhancing IGF-1 bioavailability, and activating key intracellular anabolic pathways such as PI3K/Akt/mTOR. Its additional components may improve signaling efficiency through antioxidant and anti-inflammatory effects. However, its classification as an exceptionally powerful IGF-1 signaler should be interpreted as a nuanced, context-dependent statement rather than a literal exponential superiority over other carbohydrate sources.

rep me please i want to get rep back

 

[paralyzed]

honey is the best igf one signaler carbs and sugar makes it the best igf signaler

bump

 

[Dehego]

im gonna stick to eating my brainsludge

 

[paralyzed]

im gonna stick to eating my brainsludge

jester

 

[dookiebootybutt59]

dnr

 

[paralyzed]

dnr

why

 

[irlesper]

Honey can be framed, in a highly elaborated and more technical biochemical context, as a potent modulator of insulin and insulin-like growth factor (IGF-1) signaling pathways due to its unique composition of rapidly bioavailable carbohydrates, minor bioactive compounds, and its metabolic effects on endocrine responses.
At its core, honey is a supersaturated solution primarily composed of monosaccharides—predominantly fructose (~38%) and glucose (~31%)—alongside smaller quantities of disaccharides, oligosaccharides, amino acids, organic acids, vitamins, and polyphenolic compounds. The glucose fraction, in particular, is critical in stimulating pancreatic β-cell activity, leading to insulin secretion. Insulin, beyond its classical role in glucose homeostasis, functions as a key upstream regulator of the IGF-1 axis by enhancing hepatic production of IGF-1 and reducing levels of IGF-binding proteins (especially IGFBP-1), thereby increasing free, bioactive IGF-1 in circulation.
From an endocrinological perspective, the ingestion of honey results in a glycemic response that, while sometimes moderated compared to pure glucose due to its fructose content and matrix effects, still provides a sufficiently robust insulinotropic stimulus. This insulin response activates the PI3K/Akt/mTOR signaling cascade, a central intracellular pathway responsible for anabolic processes such as protein synthesis, cell proliferation, and inhibition of apoptosis. IGF-1 signaling converges on many of these same pathways, particularly through activation of the IGF-1 receptor (IGF1R), a receptor tyrosine kinase that shares significant downstream overlap with insulin signaling.
Fructose, while not directly insulinogenic to the same degree as glucose, plays an indirect but important role. Hepatic metabolism of fructose leads to increased glycogen storage and can influence systemic energy balance, which in turn modulates growth factor signaling. Additionally, fructose metabolism bypasses key regulatory steps in glycolysis, potentially contributing to increased substrate availability for de novo lipogenesis and cellular energy status, factors that can influence mTOR activation and thereby potentiate IGF-related anabolic signaling under certain conditions.
Honey also contains trace amounts of amino acids, including proline, which may contribute marginally to anabolic signaling by supporting protein synthesis and cellular growth pathways. More interestingly, its polyphenols and flavonoids—such as quercetin, kaempferol, and chrysin—can exert modulatory effects on oxidative stress and inflammation. Reduced oxidative stress can enhance insulin sensitivity, thereby amplifying the downstream effects of insulin and IGF-1 signaling. Improved insulin sensitivity means that for a given مقدار of carbohydrate intake, the signaling efficiency through insulin and IGF pathways is enhanced, potentially increasing the net anabolic response.
In a comparative sense, positioning honey as a “superior” IGF-1 signaler relative to other carbohydrate sources would depend on several contextual variables: glycemic index, glycemic load, micronutrient composition, and metabolic health of the individual. While honey does contain additional bioactive compounds absent in refined sugars, the magnitude of its effect on IGF-1 signaling is not orders of magnitude greater in a strict quantitative biochemical sense. The claim of it being “30 times stronger” would not be supported under controlled physiological measurements; however, qualitatively, its combined effects on insulin secretion, hepatic metabolism, and cellular signaling pathways can be described as synergistic.
Furthermore, chronic consumption patterns must be considered. Persistent elevation of insulin and IGF-1 signaling is associated with both anabolic benefits (such as muscle growth and tissue repair) and potential long-term risks (including contributions to insulin resistance and proliferative diseases if dysregulated). Therefore, while honey can acutely enhance signaling through these pathways due to its carbohydrate density and metabolic effects, its role should be understood within the broader framework of nutritional context, dosage, and individual metabolic response.
In summary, honey acts as a biologically active carbohydrate matrix capable of stimulating insulin release, indirectly enhancing IGF-1 bioavailability, and activating key intracellular anabolic pathways such as PI3K/Akt/mTOR. Its additional components may improve signaling efficiency through antioxidant and anti-inflammatory effects. However, its classification as an exceptionally powerful IGF-1 signaler should be interpreted as a nuanced, context-dependent statement rather than a literal exponential superiority over other carbohydrate sources.

dnr
this is ai
die in a ditch

 

[dookiebootybutt59]

why

dnr
this is ai
die in a ditch

 

[paralyzed]

high iq does not equal ai son

 

[irlesper]

high iq does not equal ai son

yadi yada shut up
there hasnt been a good thread in weeks

 

[paralyzed]

yadi yada shut up
there hasnt been a good thread in weeks

you know whos fault that is

 

[LikableLoser]

yadi yada shut up
there hasnt been a good thread in weeks

Have you seen mine?

 

[irlesper]

you know whos fault that is

moderation and godveil leaving

 

[LikableLoser]

Have you seen mine?

My guides are amazing

 

[irlesper]

Have you seen mine?

na
link them

 

[paralyzed]

na
link them

how is this not a good guide

 

[irlesper]

how is this not a good guide

bcuz this is satire and dumb

 

[LikableLoser]

how is this not a good guide

na
link them

Thread 'Under Eye Mega Guide'



Thread 'Blood Circulation Maxxing: The Most Neglected Aspect of Looksmaxxing'

 

[Asymetrical]

Good forum man

Rofl

 

[i_blame_oxytocin]

tldr

 

[i_blame_oxytocin]

aajonus bone growth formula for igf-1

 

[Jester4Foids]

Good forum man

 

[GenR]

Cool thread tho